LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 53.77 | 84.90 | 224 | 6252 | 0.0358 | 0.1693 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 53.77 | 84.90 | 5332 | 6252 | 0.8528 | 0.9493 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 53.77 | 84.90 | 6316 | 6252 | 1.0101 | 1.0032 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 53.77 | 84.90 | 6370 | 6252 | 1.0188 | 1.0060 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 55.48 | 84.90 | 242 | 6567 | 0.0368 | 0.1817 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 55.48 | 84.90 | 5522 | 6567 | 0.8408 | 0.9455 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 55.48 | 84.90 | 6672 | 6567 | 1.0159 | 1.0050 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 55.48 | 84.90 | 6744 | 6567 | 1.0268 | 1.0085 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 57.18 | 84.90 | 254 | 6963 | 0.0365 | 0.1881 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 57.18 | 84.90 | 5865 | 6963 | 0.8423 | 0.9467 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 57.18 | 84.90 | 7055 | 6963 | 1.0132 | 1.0041 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 57.18 | 84.90 | 7116 | 6963 | 1.0219 | 1.0068 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 58.88 | 84.90 | 268 | 7291 | 0.0368 | 0.1959 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 58.88 | 84.90 | 6136 | 7291 | 0.8415 | 0.9470 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 58.88 | 84.90 | 7331 | 7291 | 1.0054 | 1.0017 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 58.88 | 84.90 | 7408 | 7291 | 1.0159 | 1.0049 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 60.59 | 84.90 | 272 | 7641 | 0.0356 | 0.1964 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 60.59 | 84.90 | 6427 | 7641 | 0.8410 | 0.9474 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 60.59 | 84.90 | 7733 | 7641 | 1.0119 | 1.0037 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 60.59 | 84.90 | 7797 | 7641 | 1.0203 | 1.0062 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 62.29 | 84.90 | 264 | 7934 | 0.0333 | 0.1892 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 62.29 | 84.90 | 6801 | 7934 | 0.8571 | 0.9535 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 62.29 | 84.90 | 8002 | 7934 | 1.0085 | 1.0026 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 62.29 | 84.90 | 8073 | 7934 | 1.0175 | 1.0053 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 63.99 | 84.90 | 310 | 8212 | 0.0377 | 0.2170 | MN20160318_Q02 | D22 |